Skip to main content
. Author manuscript; available in PMC: 2020 Mar 21.
Published in final edited form as: Psychoneuroendocrinology. 2018 Dec 13;102:281–291. doi: 10.1016/j.psyneuen.2018.12.016

Table 1.

Participant characteristics

Variables Boys Girls
n 32 47
Age 12.54 (0.95) 11.52 (0.83)
BMI 20.90 (3.15) 20.33 (3.80)
Tanner stage 1–2 (%) 43 41
Tanner stage 3–5 (%) 57 59
PDS – totala 2.77 (1.05) 3.07 (0.99)
PDS – adrenal axisa 2.66 (1.21) 2.99 (1.07)
PDS – gonadal axisa 2.88 (1.24) 3.17 (1.13)
Composite z-score adrenal axis 2.73 (1.02) 2.89 (0.95)
Composite z-score gonadal axis 2.81 (0.81) 3.09 (0.95)
Composite z-score total 2.77 (0.82) 2.99 (0.89)
DHEAraw 119.32 (21.82) 172.93 (15.18)
DHEAlogb 5.49 (0.59) 5.85 (0.64)
Testosteroneraw 100.86 (15.47) 55.63 (3.71)
Testosteronelogb 5.12 (0.57) 4.71 (0.44)
Estradiolraw n/a 1.56 (0.09)
Estradiollogb n/a 1.02 (0.16)

Note: Table values represent means, with standard deviations in parentheses, unless otherwise reported. DHEA: Dehydroepiandrosterone. BMI: Body Mass Index (n=30 boys and n=47 girls); Tanner staging data was available for 74 participants. DHEA and testosterone: n=30 boys and n=46 girls; estradiol: n=45 girls.

a

Ranging from 1 (development has not yet begun) to 5 (development seems complete).

b

Empirical Bayesian estimation scores that have been log transformed

HHS Vulnerability Disclosure